BBZA

BB Biotech AG

DE Healthcare Biotechnology

Latest week
10 Jul 2026
Close
33.400002
Fair value
34.372638
Next-week expectancy
Negative 10.22%
Sharemaestro

BBZA Chart Pack

BB Biotech AG

Exchange
GER
Latest week
10 Jul 2026
Close
33.400002
Fair value
34.372638
Next-week expectancy
Negative 10.22%
Generated
17 Jul 2026 14:30
Sector
Healthcare
Industry
Biotechnology

Chart Summary

Over the latest 12 completed weeks ending 2026-07-10, BBZA was broadly unchanged, moving from 33.40 to 33.40. The latest weekly close is above the Trend Line and below Fair Value. Trend Signal is active on the latest week and was active in 12 of the last 12 weeks. Relative Strength is 1.32 and has softened across the 12-week window. Market Dynamics is 0.03 on the latest week. Next-week expectancy is negative at 10.22% based on similar historical setup states.

Key Points

Week Ending
10 Jul 2026
Latest Close
33.40
12-Week Change
0.00%
Trend Signal
Active
Next-Week Expectancy
Negative 10.22%
Signal Weeks
12 of 12
Vs Trend Line
Above
Vs Fair Value
Below
Relative Strength
1.32
Market Dynamics
0.03

Weekly Price

Weekly Close Trend Line Fair Value Activity Lines

Chart Panels

Choose up to 5 panels. Drag panel headers to reorder.

Chart Summary

Key Points

Week Ending
10 Jul 2026
Latest Close
33.40
12-Week Change
0.00%
Trend Signal
Active
Next-Week Expectancy
Negative 10.22%
Signal Weeks
12 of 12
Vs Trend Line
Above
Vs Fair Value
Below
Relative Strength
1.32
Market Dynamics
0.03

Over the latest 12 completed weeks ending 2026-07-10, BBZA was broadly unchanged, moving from 33.40 to 33.40. The latest weekly close is above the Trend Line and below Fair Value. Trend Signal is active on the latest week and was active in 12 of the last 12 weeks. Relative Strength is 1.32 and has softened across the 12-week window. Market Dynamics is 0.03 on the latest week. Next-week expectancy is negative at 10.22% based on similar historical setup states.

Industry Peers

Germany equities in Biotechnology

Stock Exchange Week Open High Low Close Change
GE9 GENMAB AS N GER 10 Jul 2026 246.20 257.90 246.20 257.90 4.75%
HPHA Heidelberg Pharma AG GER 10 Jul 2026 2.56 2.79 2.56 2.66 3.91%
B72 AtaiBeckley Inc. GER 10 Jul 2026 4.46 4.72 4.24 4.60 3.14%
RGO Regeneron Pharmaceuticals, Inc. GER 10 Jul 2026 574.00 587.60 563.50 579.30 0.92%
PSH0 Sernova Biotherapeutics Inc GER 10 Jul 2026 0.08 0.09 0.08 0.08 0.00%
FYB Formycon AG GER 10 Jul 2026 19.30 19.58 18.24 18.80 -2.59%
NP5 Newron Pharmaceuticals S.p.A. GER 10 Jul 2026 13.40 13.50 12.80 13.05 -2.61%
PTP Pentixapharm Holding AG N GER 10 Jul 2026 2.28 2.32 2.00 2.18 -4.39%
AYJ Valneva SE GER 10 Jul 2026 2.32 2.35 2.19 2.19 -5.39%
VX1 Vertex Pharmaceuticals Incorporated GER 10 Jul 2026 463.40 464.00 424.15 425.60 -8.16%

Next-week expectancy

Next-week expectancy is a short-term historical read. It compares the latest completed-week setup with broadly similar past setups and asks whether the following week tended to close higher or lower.

It is not a trend call, a price target, or a guarantee. A positive read can appear while price is below trend or activity pressure is weak, because it is measuring short-term follow-through odds for the current setup state.

Use it as one context layer beside Trend Line, Relative Strength, Market Dynamics, Fair Value, and the visible price structure.